Metabolic bone disorders like osteoporosis, osteomalacia, and Paget’s disease present unique healthcare challenges in Canada and LATAM, as highlighted by a GRG Health case study. The research uncovered significant regional disparities: while Canada benefits from advanced diagnostics like DEXA scans, enabling improved disease management, LATAM struggles with limited access to diagnostics and treatments, particularly in rural areas. Only 60% of LATAM specialists have routine access to DEXA scans compared to 90% in Canada.
The study suggests region-specific solutions, such as AI-based fracture risk assessment and telemedicine in Canada, and public-private partnerships, rural healthcare investments, and cost-effective interventions in LATAM. These insights aim to bridge gaps, enhancing healthcare access and patient outcomes. By addressing these disparities, stakeholders can advance equitable care and improve quality of life for individuals with metabolic bone disorders.